Bosentanlet and disease progression Patient Reports February 13, 2012

Bosentanlet Side Effects Report #6055887-6
Bosentanlet side effect was reported by a Physician from UNITED KINGDOM on Jan 12, 2009. Female patient, 55 years of age, was diagnosed with idiopathic pulmonary fibrosis and was treated with Bosentanlet. After drug was administered, patient experienced the following side effects: disease progression, idiopathic pulmonary fibrosis, oedema peripheral, off label use, respiratory failure, right ventricular failure. Bosentanlet dosage: unknown. During the same period patient was treated with ATROVENT, BUMETANIDE, AZATHIOPRINE, NEOCLARITYN, CARBOCISTEINE, CALCI CHEW D, RAMIPRIL, SALBUTAMOL. Patient was hospitalized. Patient died on 01/03/2009.

Bosentanlet Side Effects Report #6099683-2
Bosentanlet side effect was reported by a Physician from UNITED KINGDOM on Feb 12, 2009. Female patient, 55 years of age, was diagnosed with idiopathic pulmonary fibrosis and was treated with Bosentanlet. After drug was administered, patient experienced the following side effects: disease progression, idiopathic pulmonary fibrosis, off label use, respiratory failure, right ventricular failure. Bosentanlet dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with ATROVENT, BUMETANIDE, AZATHIOPRINE, NEOCLARITYN, CARBOCISTEINE, CALCI CHEW D, RAMIPRIL, SALBUTAMOL. Patient was hospitalized. Patient died on 01/03/2009.